Effect of amantadine on the sleep-wake cycle of an inpatient with brain injury

Samir Al-Adawi, Heather Hoaglin, Fariba Vesali, Atsu S S Dorvlo, David T. Burke

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: A previous study suggested that the routine use of drugs intended to improve attention and arousal, such as methylphenidate, tend to have a variable but not significant effect on sleep-wake cycles. As amantadine is a frequently employed drug in brain injury rehabilitation, with known effects on fatigue and motor processing speed, this study examined the effect of amantadine on the sleep-wake behaviour of patients with brain injury undergoing rehabilitation. Method: This was a naturalistic observation using an observationally defined sleep-wake distribution for a total of 43 subjects with brain injury. Identified patients were observed for a full 24 hours a day 2 weeks before and 2 weeks after starting amantadine. Some of these patients (n = 12) had been administered amantadine on clinical grounds and, for this paper, served as the experimental group, while the drug naive (n = 31) served as a control. Three outcome measures were operationalized: hours of sleep in 24 hours, hours of sleep during daytime and hours of sleep during night-time. Result: The average number of hours of sleep during a 24-hour period was not significantly different for the two cohorts. Similarly hours of sleep during daytime and hours of sleep during night-time were on average the same for the two groups. The data suggest that amantadine has no direct bearing on sleep/wake cycles using these parameters. Conclusion: This study fails to demonstrate that the use of amantadine on an inpatient brain injury population will affect sleep/wake quantity.

Original languageEnglish
Pages (from-to)559-565
Number of pages7
JournalBrain Injury
Volume23
Issue number6
DOIs
Publication statusPublished - Jun 2009

Fingerprint

Amantadine
Brain Injuries
Inpatients
Sleep
Rehabilitation
Pharmaceutical Preparations
Methylphenidate
Arousal
Fatigue
Observation
Outcome Assessment (Health Care)

Keywords

  • Amantadine
  • Brain injury
  • Daytime sleep
  • Night-time sleep
  • Sleep pattern

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Effect of amantadine on the sleep-wake cycle of an inpatient with brain injury. / Al-Adawi, Samir; Hoaglin, Heather; Vesali, Fariba; Dorvlo, Atsu S S; Burke, David T.

In: Brain Injury, Vol. 23, No. 6, 06.2009, p. 559-565.

Research output: Contribution to journalArticle

Al-Adawi, Samir ; Hoaglin, Heather ; Vesali, Fariba ; Dorvlo, Atsu S S ; Burke, David T. / Effect of amantadine on the sleep-wake cycle of an inpatient with brain injury. In: Brain Injury. 2009 ; Vol. 23, No. 6. pp. 559-565.
@article{7d5b0ef8b7704dcfade54381bf4cb1b0,
title = "Effect of amantadine on the sleep-wake cycle of an inpatient with brain injury",
abstract = "Background: A previous study suggested that the routine use of drugs intended to improve attention and arousal, such as methylphenidate, tend to have a variable but not significant effect on sleep-wake cycles. As amantadine is a frequently employed drug in brain injury rehabilitation, with known effects on fatigue and motor processing speed, this study examined the effect of amantadine on the sleep-wake behaviour of patients with brain injury undergoing rehabilitation. Method: This was a naturalistic observation using an observationally defined sleep-wake distribution for a total of 43 subjects with brain injury. Identified patients were observed for a full 24 hours a day 2 weeks before and 2 weeks after starting amantadine. Some of these patients (n = 12) had been administered amantadine on clinical grounds and, for this paper, served as the experimental group, while the drug naive (n = 31) served as a control. Three outcome measures were operationalized: hours of sleep in 24 hours, hours of sleep during daytime and hours of sleep during night-time. Result: The average number of hours of sleep during a 24-hour period was not significantly different for the two cohorts. Similarly hours of sleep during daytime and hours of sleep during night-time were on average the same for the two groups. The data suggest that amantadine has no direct bearing on sleep/wake cycles using these parameters. Conclusion: This study fails to demonstrate that the use of amantadine on an inpatient brain injury population will affect sleep/wake quantity.",
keywords = "Amantadine, Brain injury, Daytime sleep, Night-time sleep, Sleep pattern",
author = "Samir Al-Adawi and Heather Hoaglin and Fariba Vesali and Dorvlo, {Atsu S S} and Burke, {David T.}",
year = "2009",
month = "6",
doi = "10.1080/02699050902970745",
language = "English",
volume = "23",
pages = "559--565",
journal = "Brain Injury",
issn = "0269-9052",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Effect of amantadine on the sleep-wake cycle of an inpatient with brain injury

AU - Al-Adawi, Samir

AU - Hoaglin, Heather

AU - Vesali, Fariba

AU - Dorvlo, Atsu S S

AU - Burke, David T.

PY - 2009/6

Y1 - 2009/6

N2 - Background: A previous study suggested that the routine use of drugs intended to improve attention and arousal, such as methylphenidate, tend to have a variable but not significant effect on sleep-wake cycles. As amantadine is a frequently employed drug in brain injury rehabilitation, with known effects on fatigue and motor processing speed, this study examined the effect of amantadine on the sleep-wake behaviour of patients with brain injury undergoing rehabilitation. Method: This was a naturalistic observation using an observationally defined sleep-wake distribution for a total of 43 subjects with brain injury. Identified patients were observed for a full 24 hours a day 2 weeks before and 2 weeks after starting amantadine. Some of these patients (n = 12) had been administered amantadine on clinical grounds and, for this paper, served as the experimental group, while the drug naive (n = 31) served as a control. Three outcome measures were operationalized: hours of sleep in 24 hours, hours of sleep during daytime and hours of sleep during night-time. Result: The average number of hours of sleep during a 24-hour period was not significantly different for the two cohorts. Similarly hours of sleep during daytime and hours of sleep during night-time were on average the same for the two groups. The data suggest that amantadine has no direct bearing on sleep/wake cycles using these parameters. Conclusion: This study fails to demonstrate that the use of amantadine on an inpatient brain injury population will affect sleep/wake quantity.

AB - Background: A previous study suggested that the routine use of drugs intended to improve attention and arousal, such as methylphenidate, tend to have a variable but not significant effect on sleep-wake cycles. As amantadine is a frequently employed drug in brain injury rehabilitation, with known effects on fatigue and motor processing speed, this study examined the effect of amantadine on the sleep-wake behaviour of patients with brain injury undergoing rehabilitation. Method: This was a naturalistic observation using an observationally defined sleep-wake distribution for a total of 43 subjects with brain injury. Identified patients were observed for a full 24 hours a day 2 weeks before and 2 weeks after starting amantadine. Some of these patients (n = 12) had been administered amantadine on clinical grounds and, for this paper, served as the experimental group, while the drug naive (n = 31) served as a control. Three outcome measures were operationalized: hours of sleep in 24 hours, hours of sleep during daytime and hours of sleep during night-time. Result: The average number of hours of sleep during a 24-hour period was not significantly different for the two cohorts. Similarly hours of sleep during daytime and hours of sleep during night-time were on average the same for the two groups. The data suggest that amantadine has no direct bearing on sleep/wake cycles using these parameters. Conclusion: This study fails to demonstrate that the use of amantadine on an inpatient brain injury population will affect sleep/wake quantity.

KW - Amantadine

KW - Brain injury

KW - Daytime sleep

KW - Night-time sleep

KW - Sleep pattern

UR - http://www.scopus.com/inward/record.url?scp=67650599175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650599175&partnerID=8YFLogxK

U2 - 10.1080/02699050902970745

DO - 10.1080/02699050902970745

M3 - Article

VL - 23

SP - 559

EP - 565

JO - Brain Injury

JF - Brain Injury

SN - 0269-9052

IS - 6

ER -